122 Chapter 5 16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476): 307-10. 17. Rausch S, Hasinger O, Konig T, Schlegel A, Weiss G. An automated high throughput solution for DNA extraction and bisulfiteconversion from high volume liquid biopsy specimens: sample preparation for epigenetic analysis. BMC Res Notes 2019; 12(1): 551. 18. Floore A, Hesselink A, Ostrbenk A, Alcaniz E, Rothe B, Pedersen H, et al. Intra- and inter-laboratory agreement of the FAM19A4/miR124-2 methylation test: Results from an international study. J Clin Lab Anal 2019; 33(4): e22854. 19. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 2009; 125(11): 2489-96. 20. Holmes EE, Jung M, Meller S, Leisse A, Sailer V, Zech J, et al. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine. PLoS One 2014; 9(4): e93933. 21. Ajenifuja KO, Belinson J, Goldstein A, Desai KT, de Sanjose S, Schiffman M. Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2. Infect Agent Cancer 2020; 15: 61.
RkJQdWJsaXNoZXIy MjY0ODMw